Sixty Korean scientists have been ranked among the "top 1 percent" of the world's most influential researchers. In particular, 10 of them are among the top 1 percent of researchers in clinical medicine. All of them are specialists in hematology-oncology.
Clarivate, a global scholarly information analytics company, released its list of 7,125 Highly Cited Researchers (HCRs) in 2023 based on the number of citations of their articles on Friday (local time). The list includes researchers who published the top 1 percent of cited papers over the past 10 years in 21 different fields.
Sixty-five researchers from Korean universities and research institutes made the list. Of them, 60 were Koreans, with the other five being foreigners. Including duplicate selections in multiple fields, there were 66 HCRs from Korean universities and institutions.
The list of HCRs in clinical medicine included 10 Korean physicians, the same as last year.
Four have been selected as HCRs for four consecutive years. They are Professor Kim Dong-wan of the Department of Hematology and Oncology at Seoul National University Hospital; Professor Park Geun-chil of the Department of Hematology and Oncology at Samsung Medical Center; Bang & Ock Consulting CEO Bang Yung-jue (formerly a professor of Hematology and Oncology at Seoul National University Hospital); and Professor Ahn Myung-ju of the Department of Hematology and Oncology at Samsung Medical Center.
Professor Kang Yoon-koo of the Department of Medical Oncology at Asan Medical Center, Professor Im Seock-ah of the Hematology and Oncology Department at Seoul National University Hospital, Professor Chung Hyun-cheol of the Yonsei University College of Medicine, and Professor Cho Byoung-chul of the Department of Medical Oncology at Severance Hospital were named HCRs for the third consecutive year.
Professor Lee Ki-Hyeong of the Department of Hematology and Oncology at Chungbuk National University Hospital was selected as an HCR for the second consecutive year, and Professor Kim Sung-bae of the Department of Hematology and Oncology at Asan Medical Center was chosen for the first time this year.
Professor Lim Ho-yeong of the Department of Hematology and Oncology at Samsung Medical Center was named an HCR in the clinical medicine category last year and was named in the cross-field category this year.
Seoul National University Hospital had the most HCRs with 10, followed by Ulsan National Institute of Science and Technology (UNIST) with nine, Sungkyunkwan University with eight, Hanyang University with five, Korea University and Yonsei University with four each, and Korea Advanced Institute of Science and Technology (KAIST) with three.